78 related articles for article (PubMed ID: 3845728)
1. [Duphaston].
Lange P; Gervais C
Soins Gynecol Obstet Pueric Pediatr; 1985 Jan; (44):I-II. PubMed ID: 3845728
[No Abstract] [Full Text] [Related]
2. [Duphaston].
Lange P; Gervais C
Soins Gynecol Obstet Pueric Pediatr; 1982 Oct; (17):43-4. PubMed ID: 6925397
[No Abstract] [Full Text] [Related]
3. [Action of dydrogesterone in postpubertal menstruation disorders].
Tabaste JL; Servaud M; Steiner E; Dabir P; Bene B; Pouzet M
Rev Fr Gynecol Obstet; 1984 Jan; 79(1):19-20, 23-5. PubMed ID: 6531584
[TBL] [Abstract][Full Text] [Related]
4. [Dydrogesterone in the regulation of cycle disturbances in adolescence].
Chomczyk I; Sipowicz M; Sipowicz I
Ginekol Pol; 1999 May; 70(5):343-7. PubMed ID: 10462978
[TBL] [Abstract][Full Text] [Related]
5. [Induction of ovulation and treatment of luteal insufficiency with a new retrosteroid].
Onetto E; Galani M; Guijón F; Chapero L; Barnafi L; Naquira N; Saavedra R
Rev Chil Obstet Ginecol; 1970; 35(3):124-9. PubMed ID: 5508782
[No Abstract] [Full Text] [Related]
6. [The efficacy of dydrogesterone in the treatment of menstrual cycle disorders in girls].
Sipowicz I; Chomczyk I
Ginekol Pol; 1998 Oct; 69(10):767-70. PubMed ID: 9884472
[TBL] [Abstract][Full Text] [Related]
7. [Indications for dydroprogesterone in gynecology].
Villedieu P; Haour P
Nouv Presse Med; 1972 Sep; 1(34):2255-6. PubMed ID: 4673267
[No Abstract] [Full Text] [Related]
8. [Treatment of severe primary and secondary dysmenorrhea with a retrosteroid].
Bayer R
Wien Med Wochenschr; 1971 Sep; 121(36):618-24. PubMed ID: 5110842
[No Abstract] [Full Text] [Related]
9. Clinical uses of progestational agents in the endocrine department of Chelsea Hospital for Women.
Osmond-Clarke F
Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):522-5. PubMed ID: 5534330
[No Abstract] [Full Text] [Related]
10. [Clinical use of promegestone, a progestational agent with high specificity for receptors].
Brun G; Dargent D; Pontonnier G; Petrescou L
Rev Fr Gynecol Obstet; 1984 May; 79(5):423-6. PubMed ID: 6396815
[No Abstract] [Full Text] [Related]
11. [Studies concerning the action mechanism of a retrosteroid, RO 4-8347].
Béguin F; Keller M; Stamm O; Zarro D
Gynaecologia; 1969; 167(5):450-61. PubMed ID: 5802925
[No Abstract] [Full Text] [Related]
12. Dydrogesterone (Gynorest and Duphaston).
Med Lett Drugs Ther; 1969 Apr; 11(7):31-2. PubMed ID: 5781648
[No Abstract] [Full Text] [Related]
13. [Treatment of the premenstrual syndrome with a retroprogesterone (Duphaston)].
Strecker JR
Fortschr Med; 1980 Jan; 98(4):(145-7). PubMed ID: 7189174
[TBL] [Abstract][Full Text] [Related]
14. Indications for therapy with progestational agents.
Darragh A
Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):541-4. PubMed ID: 5534331
[No Abstract] [Full Text] [Related]
15. [Effect of the gestagen RO 4-8347].
Lutziger H
Gynaecologia; 1969; 167(5):444-9. PubMed ID: 5802924
[No Abstract] [Full Text] [Related]
16. [Therapy of endometriosis with dydrogesterone (Duphaston Depot) in delayed-action preparation form].
Obolensky W; Kamber J
Ther Umsch; 1973 Jul; 30(7):558-61. PubMed ID: 4720335
[No Abstract] [Full Text] [Related]
17. Histology and ultrastructure of human endometriotic tissues treated with dydrogesterone (Duphaston).
Cornillie FJ; Puttemans P; Brosens IA
Eur J Obstet Gynecol Reprod Biol; 1987 Sep; 26(1):39-55. PubMed ID: 3666263
[TBL] [Abstract][Full Text] [Related]
18. Duphaston depot, a new long-acting progestogen.
Schellen AM
Bull Soc R Belge Gynecol Obstet; 1969; 39(4):327-31. PubMed ID: 5408050
[No Abstract] [Full Text] [Related]
19. [Mechanism of action of dydrogesterone in dysmehorrhea. Prostaglandin levels in menstrual blood].
Zahradnik HP
Fortschr Med; 1984 Apr; 102(15):439-42. PubMed ID: 6724478
[TBL] [Abstract][Full Text] [Related]
20. [Study of 6-dehydro-retro-progesterone; especially in comparison with the effect of 17-alpha-ethynyl-19-nortestosterone].
Yamamoto K
Zasshi Tokyo Ika Daigaku; 1968 Jul; 26(3):385-403. PubMed ID: 5750349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
